HCV Infection Linked to Risk for Chronic Inflammatory Skin Diseases
The association between hepatitis C virus infection and chronic inflammatory skin diseases is assessed.
The association between hepatitis C virus infection and chronic inflammatory skin diseases is assessed.
The repigmenting efficacy and safety of phototherapy with EL or TUVB in patients with vitiligo was evaluated.
Insurance coverage for topical treatments for rosacea vs melasma are investigated.
Treatment outcomes and adverse events of oral tranexamic acid (TA) in patients with vitiligo and melasma were assessed.
COVID-19-related vitiligo treatment delays were assessed and the disease management possible during the pandemic is suggested.
Support for various systemic treatments for vitiligo is reviewed.
The clinical dermatologic use of tocilizumab, its mechanisms of action, and adverse events is reviewed.
Current knowledge about vitiligo and potential treatments are reviewed.
The efficacy of gliadin-protected to superoxide dismutase (SOD) in conjunction with phototherapy for addressing vitiligo was assessed.
Individuals with co-occurrence of vitiligo and psoriasis have an increased risk for autoimmunity and family history of psoriasis.